Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GLAUKOS Corp Director's Dealing 2023

Jul 18, 2023

31074_dirs_2023-07-18_ce327f9d-9593-4b07-a263-476bd281d9c0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GLAUKOS Corp (GKOS)
CIK: 0001192448
Period of Report: 2023-07-14

Reporting Person: Gilliam Joseph E (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-07-14 Common Stock M 19599 $41.69 Acquired 140083 Direct
2023-07-14 Common Stock M 10000 $30.92 Acquired 150083 Direct
2023-07-14 Common Stock M 10000 $39.10 Acquired 160083 Direct
2023-07-14 Common Stock M 2500 $39.10 Acquired 162583 Direct
2023-07-14 Common Stock S 42099 $78.34 Disposed 120484 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-07-14 Stock Option (Right to Buy) $41.69 M 19599 Disposed 2027-05-05 Common Stock (19599) Direct
2023-07-14 Stock Option (Right to Buy) $30.92 M 10000 Disposed 2028-03-14 Common Stock (10000) Direct
2023-07-14 Stock Option (Right to Buy) $39.10 M 10000 Disposed 2030-03-12 Common Stock (10000) Direct

Footnotes

F1: Includes 84,219 restricted stock units that have not yet vested or been delivered to the Reporting Person.

F2: This trade was made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices.

F3: This option was granted on May 5, 2017 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.

F4: This option was granted on May 5, 2017 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.

F5: This option was granted on March 12, 2020 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.